Investing Profile

Iris Wang

InvestorVC
Partner, Public Equity at OrbiMed
orbimed.comHong Kong
Photo of Iris Wang, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Credit Suisse Network
196 CONNECTIONS
Columbia University - Columbia Business School Network
176 CONNECTIONS
Columbia Business School Network
160 CONNECTIONS
Peking University Network
54 CONNECTIONS
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
6
$18B
CompanyStageDateRound SizeTotal Raised
Dingdang Kuaiyao
Private EquityJun 2021$220M
$220M
EDDA Technology
Private EquityApr 2021$150M
$150M
LakeShore Biopharma
Series BFeb 2021$130M
$130M
Harbour Biomed
Series CJul 2020$100M
$100M
Akeso Biopharma
Series DNov 2019$150M
$150M
Alphamab Oncology
Series ANov 2018$100M
$160M
Co-investors: Adrian Cheng (K11 Concepts Limited)
Director Credit SuissePresent
Director, Public Equity, Asia OrbiMedPresent
Managing Director, Public Equity, Asia OrbiMedPresent
Managing Director OrbiMedPresent
Partner OrbiMedPresent
Partner, Public Equity OrbiMedPresent
Founding Partner HotmailPresent
Peking University Bachelor's degree Biological Sciences and Economics
Columbia Business School Master of Business Administration - MBA Value Investing
Columbia University - Columbia Business School Master of Business Administration - MBA Value Investing